baber/WOPTO huggingface dataset:
Patent MX-159030-A (MX)
Inventor: HOCH DIETRICH
IPC: A61Q5/04
Filed: 1984-01-17
Abstract: PCT No. PCT/EP83/00350 Sec. 371 Date Aug. 10, 1984 Sec. 102(e) Date Aug. 10, 1984 PCT Filed Dec. 29, 1983 PCT Pub. No. WO84/02842 PCT Pub. Date Aug. 2, 1984.Process for a selective permanent shaping of the regrowth of hair, whereby the hair is at first treated with a liquid aqueous pretreatment substance, is rolled onto rollers, is treated with a aqueous reducing permanent shaping substance, rinsing, fixing it oxidatively and further treating it in a customaty manner, characterized in that the pretreatment and the permanent shaping substance is so selected that they form a separating layer at their contact face (uppermost layers of the rolled up hair) during contact, thus making an admixture of the pretreatment substance with the permanent substance more difficult or prevent it. Suitable combinations are for example: Pre=treatment substance containing either a high polymeric polycarboxylic acid polymer, whereby at least 25% Mol of these polymers consists of a free carboxylic acid group, or a water soluble aluminum salt in combination with an alkalic permanent shaping substance.
Patent NZ-181366-A (NZ)
Title: Composite focusing and centring detector for optical record reading
Inventor: LAM H
IPC: G11B7/00
Filed: 1976-07-05
Abstract: An apparatus is described for reading a radiation-reflecting record carrier on which information is stored in an optically readable track-shaped phase structure. The apparatus inter alia includes a radiation source, an objective system and a radiation-sensitive detection system. By a suitable arrangement and a suitable choice of the power of a cylindrical lens, which lens in conjunction with a four-quadrant detector supplies a focussing signal, it is possible to detect centering-errors with the aid of only two additional detectors in the plane of the four-quadrant detector.
Patent NZ-227125-A (NZ)
Title: Quinazoline derivatives and pharmaceutical compositions
Inventor: IFE ROBERT JOHN
IPC: C07D239/95
Filed: 1988-11-29
Abstract: Compounds of structure (I): <CHEM>  in which   R<1> to R<4> are the same or different and are each hydrogen, C1-4alkyl, C1-4alkoxy, phenyl, C1-4alkylthio, C1-4alkanoyl, amino, C1-6alkylamino, diC1-4alkylamino, halogen or trifluoromethyl provided that at least two of R<1> to R<4> are hydrogen. R<5> and R<6> are the same, or different and are each hydrogen, C1-4alkyl, -(CH2)nAr in which n is 0 to 4 and Ar is an optionally substituted phenyl group, or R<5> and R<6> together with the nitrogen atom to which they are attached form a saturated or unsaturated carbocyclic ring; and; R<7> and R<8> are the same or different and are each hydrogen, C1-4alkyl, (CH2)nAr<1> in which n is 0 to 4 and Ar<1> is an optionally substituted phenyl group, or R<7> and R<8> together with the nitrogen atom to which they are attached form a saturated or unsaturated carbocyclic ring; and pharmaceutically acceptable salts thereof, processes for their preparation, pharmaceutical compositions containing them and their use in therapy as inhibitors of gastric acid secretion.
Patent NZ-228014-A (NZ)
Title: Lightsafe masking film for use in photomechanical reproduction processes
Inventor: MARUYAMA HIROSHI
IPC: G03F1/90
Filed: 1989-02-16
Abstract: A lightsafe masking film is disclosed which comprises a substrate, and a peelable lightsafe layer provided over the surface of the substrate and including a lightsafe substance, a copolymer containing vinyl chloride, and a mixture of a first nitrile rubber containing 25-30 % by weight of acrylonitrile and a second nitrile rubber containing 31-35 % by weight of acrylonitrile.
Patent NZ-234506-A (NZ)
Title: Method preventing viscosity increase of aqueous calcium carbonate pigment suspensions
Inventor: RAVET GEORGES
IPC: C09K23/52
Filed: 1990-07-13
Abstract: The viscosity increase of aqueous calcium carbonate pigment suspensions having high concentrations of dry substance is prevented by adding as a compatibility, dispersing, and/or grinding agent to an aqueous calcium carbonate suspension a copolymer of the formula: <IMAGE>  wherein R1 is H or methyl, R2 and R3 is H, C1-4 alkyl or a carboxylic acid group, R4 is H or C1-4 alkyl, R5 is a bridging group, R6 is H, a cation, an amino group, C1-3 alkyl, C1-4 ester or substituted amide and R7 to R9 each is hydrogen, a carboxylic acid containing group; K has a value between 30 and 65% by weight relative to the total weight; L has a value between 20 and 60% by weight relative to the total weight; M has a value between 10 and 45% by weight relative to the total weight; and the sum of L and M is equal to at least 35% by weight relative to the total weight, thereby preventing the shock effect when a concentrated alkaline electrolyte is added to the suspension.
Patent NZ-239182-A (NZ)
Title: N-sulphonylindoline derivatives and pharmaceutical compositions
Inventor: WAGNON JEAN
IPC: A61K31/40
Filed: 1991-07-30
Abstract: Compounds of formula: <IMAGE>  in which   - R1 denotes a halogen atom, a C1-C4 alkyl or alkoxy, a hydroxyl or a benzyloxy, cyano, trifluoromethyl, nitro or amino group; - R2 denotes a C1-C6 alkyl, a C3-C7 cycloalkyl, a C5-C7 cycloalkene, a phenyl, unsubstituted or mono- or polysubstituted by a C1-C4 alkyl or alkoxy, a halogen or a trifluoromethyl, nitro or amino group;   - R3 denotes a hydrogen atom or a C1-C4 alkyl; - R4 denotes a carboxyl group, a C1-C6 alkoxycarbonyl group, a benzyloxycarbonyl group or a carboxamide group of formula CONR6R7; - R5 denotes a C1-C4 alkyl, 1-naphthyl, 2-naphthyl, 5-dimethylamino-1-naphthyl, phenyl, unsubstituted or substituted by one or more substituents chosen from a halogen, a C1-C4 alkyl, a trifluoromethyl, nitro, amino group free or substituted by one or 2 C1-C4 alkyls, a hydroxyl, a C1-C4 alkoxy, a C1-C4 alkenoxy, a C1-C4 alkylthio or a trifluoromethoxy, benzyloxy, cyano, carboxyl, C1-C4 alkoxycarbonyl, carbamoyl or C1-C4 alkylamido group or, when m = 0, R5 may denote a group: <IMAGE> - each of R6 and R7 independently denotes hydrogen, a C1-C6 alkyl, a phenylalkyl in which the alkyl is C1-C4 or R6 and R7 together form a -(CH2)p- group;   - n denotes 0, 1 or 2;   - m denotes 0, 1 or 2;   - p denotes 4, 5 or 6;  and their optional salts. These compounds have an affinity for the vasopressin and ocytocin receptors.
Patent NZ-240676-A (NZ)
Title: Heterocyclic compounds substituted by a (piperidin-4-yl)-1-oxoalkyl group and pharmaceutical compositions thereof
Inventor: GIICHI GOTO
IPC: C07D/
Filed: 1991-11-20
Abstract: A condensed heterocyclic derivative of the formula (I): <CHEM> wherein X is an oxygen atom, a sulfuir atom or R<1>-N< wherein R<1> is a hydrogen atom, a hydrocarbon group which may be substituted or an acyl group which may be substituted; R<2> is a hydrogen atom or a hydrocarbon group which may be substituted; ring A is a benzene ring which may be substituted, k is a whole number of 0 to 3; m is a whole number of 1 to 8; and n is a whole number of 1 to 6, or a salt thereof exhibiting high colinesterase inhibitory activity, and a method for producing the same.
Patent NZ-242890-A (NZ)
Title: Storable evaporated milk product containing fats
Inventor: SCHWAN MICHAEL
IPC: A23C3/037
Filed: 1992-05-25
Abstract: In order to prepare sterilised, evaporated, whole milk, without or with a very small addition of stabilising additives, the standardised milk is subjected to partial homogenisation and then heat treatment before concentration by means of evaporation. The evaporated milk is sterilised after being placed in containers or on line, before filling, in which case the containers are filled aseptically. 
<??>The evaporated milk obtained is preserved at ambient temperature without deposition, gelling or separation of the fat.
Patent NZ-247149-A (NZ)
Title: Cyclic peptide antifungal agents and compositions thereof
Inventor: BURKHARDT FREDERICK JOSEPH
IPC: C07K14/41
Filed: 1993-03-15
Abstract: Provided are compounds of the formula (1): <CHEM>  wherein R' is hydrogen, methyl or NH2C(O)CH2-;     R'' is methyl or hydrogen;     R is hydroxy or hydrogen;     R1 is hydroxy, hydrogen, or hydroxysulfonyloxy;     R7 is hydroxy, hydrogen, hydroxysulfonyloxy or phosphonooxy; R2 is a novel acyl side chain. Also provided are novel formulations, methods of inhibiting fungal and parasitic activity, and a process for preparing dideoxy (R=H) forms of the compounds.
Patent NZ-250150-A (NZ)
Title: Tinting hydrophilic contact lenses in the unhydrated state
Inventor: AUTEN RICHARD D
IPC: G02C7/04
Filed: 1993-11-05
Abstract: Tinting comprises: (a) providing an unhydrated contact lens; (b) providing a dyestuff soln.; (c) providing a printing block comprising a hydrophilic polymer material contg. a dye complexing agent capable of non-covalently bonding the dyestuff; (d) placing the dyestuff soln. onto the printing block; (e) contacting the unhydrated contact lens and the printing block for a time sufficient to allow the dyestuff soln. to diffuse to the lens; and (f) removing the lens from the printing block.
Patent NZ-288037-A (NZ)
Title: Use of 2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno[2,3-b][1,5]benzo diazepine in the manufacture of a medicant for the treatment of alzheimer's disease
Inventor: BEASLEY CHARLES MERRITT
IPC: A61K/
Filed: 1995-05-30
Abstract: A method for treating a cognitive dysfunction comprises admin. of 2-methyl-4-(4-methyl-1-piperazinyl)-10H- thieno 2,3-b 1,5 benzodiazepine (I) or its salts.
Patent NZ-311254-A (NZ)
Title: Processing of (bi,pb)scco superconductor in wires and tapes
Inventor: LI QI
IPC: C04B35/65
Filed: 1996-06-05
Abstract: A process of the production and processing of high quality, high Tc (Bi,Pb)SCCO superconductors, starting with fabrication of a precursor article including selected intermediate phases with desired chemical and structural properties.  The precursor fabrication includes introducing the reacted mixture having a dominant amount of the tetragonal BSCCO (Bismuth-Strontium-Calcium-Copper-Oxide) phase into a metal sheath, and sealing the reacted mixture within the sheath, heating the mixture at a second selected processing temperature in an inert atmosphere with a second selected oxygen partial pressure for a second selected time period, the second processing temperature and the second oxygen partial pressure being co-operatively selected to form a dominant amount of an orthorhombic BSCCO phase in the reacted mixture.  The sealed sheath is deformed to form an elongated precursor article of a desired texture and thereafter heated at a third selected processing temperature in an inert atmosphere with a third selected oxygen partial pressure for a third selected time period.  The third processing temperature and third oxygen partial pressure are co-operatively selected to convert at least a portion of the orthorhombic BSCCO phase to the final superconducting BSCCO material.
Patent NZ-331418-A (NZ)
Title: Iscom or iscom-matrix comprising hydrophobic receptor molecules for antigenic substances
Inventor: MOREIN BROR
IPC: A61K9/00
Filed: 1997-02-20
Abstract: The lipid-containing particles, being iscoms or iscom-matrices, are characterised in that they comprise one or more lipid-containing receptors for antigen substances from microorganisms, bacteria toxins, fimbria, adhesines and binding active parts thereof.  The receptors have been integrated in the particle and are chosen from lipid-containing receptors or receptors that are hydrophobic.
Patent NZ-331449-A (NZ)
Title: Icom or iscom matrix vaccines for stimulating immune response in juvenile individuals
Inventor: MOREIN BROR
IPC: A61K39/175
Filed: 1997-02-20
Abstract: This use of immunogenic complexes in the form of iscom containing at least one glycoside, at least one lipid and at least one antigen or an iscom matrix containing at least one glycoside and at least one lipid is for preparing vaccines that evoke immune responses in juveniles with immature immune system and or with maternal immunity.
Patent NZ-332772-A (NZ)
Title: Isolated nucleic acid molecules which encode a MAPE-B gene or variant useful in screening for types of cancer
Inventor: LURQUIN CHRISTOPHE
IPC: C12Q1/68
Filed: 1997-06-05
Abstract: An isolated nucleic acid molecule consists of genomic DNA encoding a MAGE-B gene consisting of: a) nucleotides 3266-7979 of SEQ ID NO:15; b) nucleotides 23546-25194 of SEQ ID NO:15; c) nucleotides 29748-31474 of SEQ ID NO:15; d) nucleotides 29748-31827 of SEQ ID NO:15 or e) nucleotides 31403-39691 of SEQ ID NO:15.  An isolated nucleic acid molecule encodes a MAGE-B1 variant, consisting of, in 5' to 3' order: f) nucleotides 31403-31474, 33958-34062, 35057-35139 and 38088-39691 of SEQ ID NO:15; g) nucleotides 31403-31474, 33958-34062, and 38088-39691 of SEQ ID NO:15; h) nucleotides 35057-35139 and 38088-39691 of SEQ ID NO:15 or i) nucleotides 33958-34062 and 38088-39691 of SEQ ID NO:15. An isolated nucleic acid molecule having a nucleotide sequence as set forth in SEQ ID NO:12; SEQ ID NO:16; SEQ ID NO:17 or SEQ ID NO:18 is useful as an oligonucleotide primer. A method for screening for possibility of a testicular seminoma, non-small cell lung carcinoma, melanoma-1 breast cancer, sarcoma or leukemia in a sample, comprises: contacting the sample with at least one nucleic acid molecule which hybridizes to mRNA corresponding to an MAGE-Xp gene, and then determining hybridization as a determination of possible presence of testicular seminoma, non-small cell lung carcinoma, melanoma, breast cancer, sarcoma or leukemia in the sample. A method for determining presence of leukemia, lymphoma, head and neck squamous cell carcinoma, or mammary carcinoma in a sample, comprises: assaying the sample for mRNA for MAGE-B2, wherein presence of the mRNA is indicative of possibility of leukemia, lymphoma, head and neck squamous cell carcinoma, or mammary carcinoma in the sample. A method for determining presence of skin carcinoma mammary carcinoma, comprises: assaying a sample for presence of mRNA for MAGE-B1 gene, wherein presence of the  mRNA is indicative of possibility of skin carcinoma or mammary carcinoma in the sample.
Patent NZ-333127-A (NZ)
Title: Recycling process for producing plastic materials using plastics of differing composition, type or grade and a fatty acid or a derivative thereof
Inventor: SCHALLENBERG GUNTER
IPC: B29B17/00
Filed: 1997-06-10
Abstract: The invention relates to a process for recycling and producing plastics, plastics mixtures or from sorted and unsorted plastic waste wherein: a) a carrier material A, a material X and an additive Z are mixed together, where A and X together, in relation to the total volume, contain at least a quantity of plastics such that the non-plastic components are incorporated therein while a homogenous or partially homogenous composition is still forming; b) the mixture is transported by a conveying device and subjected along the conveyor path to a multistage thermal  treatment in sections while continuing to be subjected to mechanical mixing, kneading or compressing and c) the thermal-treated mixture is ejected through a nozzle for further treatment or shaping. The granular size of the material entering the device for the thermal treatment in step b) is 1 to 5 mm in diameter. The multistage thermal treatment of step b) comprises at least three stages with the temperature in: i) a first stage, 60-1300C; ii) a second stage, 130-1800C and iii) a third stage, 1600-3800C. Carrier material A comprises newly produced plastic material or plastics waste material comprising a uniform type of plastic or various plastics. The material X is a material of any or unknown composition. The additive Z is fatty acids, fatty acid-containing mixtures of natural or synthetic origin, fatty acid derivatives releasing fatty acids under process conditions or fatty alcohols.
Patent NZ-333315-A (NZ)
Title: Dipyridoxyl chelating agents and their metal chelates for treating free radicals induced conditions
Inventor: KARLSSON JAN OLOF GUSTAV
IPC: A61K31/661
Filed: 1997-06-24
Abstract: This use of the chelating agents of the formula (I) or metal chelates thereof is in the manufacture of a therapeutic agent for use in the treatment or prophylaxis of conditions resulting from the presence of free radicals in the human or non-human animal body, particularly in relieving symptoms associated with reperfusion of ischemic tissue and in treating or preventing radiation-induced injury. The moieties of the compounds of formula (I) are defined as: each R1 independently represents hydrogen or -CH2COR5; R5 represents hydroxy, optionally hydroxylated alkoxy, amino or alkylamido; each R2 independently represents a group XYR6; X represents a bond, or a C1-3 alkylene or oxoalkylene group optionally substituted by a group R7; Y represents a bond, an oxygen atom or a group NR6; R6 is a hydrogen atom, a group COOR8, an alkyl, alkenyl, cycloalkyl, aryl or aralkyl group optionally substituted by one or more groups selected from COOR8, CONR82, NR82, OR8, =NR8, =O, OP(O) (OR8)R7 and OSO3M; R7 is hydroxy, an optionally hydroxylated, optionally alkoxylated alkyl or aminoalkyl group; R8 is a hydrogen atom or an optionally hydroxylated, optionally alkoxylated alkyl group; M is a hydrogen atom or one equivalent of a physiologically tolerable cation; R3 represents a C1-8 alkylene group, a 1,2-cycloalkylene group, or a 1,2-arylene group; and each R4 independently represents hydrogen or C1-3 alkyl).
Patent NZ-334030-A (NZ)
Title: Synthesis of bisindolylmalimides
Inventor: FAUL MARGARET MARY
IPC: C07D403/14
Filed: 1997-08-22
Abstract: The process for the preparation of formula (I), comprises reacting an optionally substituted  indole-3-acetamide of formula (II),  with optionally substituted methyl indole-3-glyoxyl reagent of the formula (III), in the presence of a base sufficiently strong to deprotonate the amide and methylene at the C-3 position of the indolyl-3-acetamide. In formula (I), (II) and (III); R1 and R2 independently are optionally substituted 3-indolyl, R3 is I, Cl, Br, or OR4, R4 is C1-C4 alkyl, and R11 is CH3 or H. The compound of formula (I) can be used in a medicament as an inhibitor of Protein Kinase C.
Patent NZ-334051-A (NZ)
Title: Optical record disc encased in integral plastic film with rim providing inertial balance ring
Inventor: BURROUGHS TREVOR ALAN
IPC: G11B7/24097
Filed: 1996-01-10
Abstract: An optical data medium 60 (disk) enclosure has a first planar transparent film 30 to overlie the read surface of the disk and a second planar transparent film 50 to overlie the non-read surface of the disk.  Either or both of the films has a rim 20, 40 of L-shaped cross-section which extends around the periphery of the disk.  The rim has a mass sufficient so that the inertia of the rim whilst the disk is spinning corrects for imbalances of the enclosed disk.
Patent NZ-335720-A (NZ)
Title: Harvester (typically for kumara) with blade, in front of conveyor, having differing degrees of inclination, and such blade for harvester
Inventor: SLACK MARK
IPC: A01D17/00
Filed: 1999-05-12
Abstract: Blade 71 has ramp(s), typically central and side ramps 72, 73, 74 to impart different degrees of elevation to dug earth and associated crops across the blade width.  Such ramping is stated to provide a channeling effect to direct crops such as kumaras to positions accessible by sorters.
Patent NZ-500629-A (NZ)
Title: A structural steel member comprising nested Z-sections
Inventor: WEEKS KEVIN WILLIAM
IPC: E04C3/09
Filed: 1998-04-30
Abstract: The specification describes a structural member (10) for the use as a chord (41, 42) for forming a roof truss (40) for a building.  Broadly described is an elongated open structural (10) member having a cross section including a minor flange (12), a major flange (13), and a web (14) interconnecting said flanges and having a section axis (11a) at right angles to the longitudinal axis (11b) of the structural member (10) and passing through the flanges (12, 13) and wherein said web (14) includes a linear portion (17) substantially coincident with the section axis (11a) and a divergent portion (18) which extends to one side of said section axis (11a).  The minor flange (12) extends to one side of the section axis (11a).  The major flange (13) extends from the divergent portion (18) to the opposite side of the section axis (11a), and the section configuration is such that an inverted and reversed corresponding open member is nestable within the open structural member (10) with their respective linear section portions (17) alongside one another and with each minor flange (12) located in an abutting relationship against the underside of the adjacent major flange (13).
Patent NZ-500787-A (NZ)
Title: Valve including means to restrict fluid flow between inlet and outlet
Inventor: SABA TARAZ U LLAH
IPC: F16K3/08
Filed: 1999-11-02
Abstract: A valve (100) for controlling gas flow for gas heating which allows a more gradual or smoother transition from high flow to low flow.  Includes ability to control gas burners with multiple gas rings with single appliance valve, graduated or stepped control over gas flow, modular construction allowing valves to be ganged together forming a common inlet (104) manifold, partial or complete construction composite materials, and the ability to turn off in both directions but turn on only to high flow.
Patent NZ-501571-A (NZ)
Title: Novel n-substituted urea inhibitors of farnesyl-protein transferase
Inventor: REMISZEWSKI STACY
IPC: A61K31/4545
Filed: 1998-06-15
Abstract: A compound of the formula (1.0) or a pharmaceutically acceptable salt or solvate thereof, wherein: A represents N or N-oxide; X represents N, CH or C, such that when X is N or CH, there is a single bond to carbon atom 11 as represented by the solid line; or when X is C, there is a double bond to carbon atom 11, as represented by the solid and dotted lines; X1 and X2 are independently selected from bromo or chloro, and X3 and X4 are independently selected from hydrogen, bromo or chloro provided that at least one of X3 and X4 is hydrogen; Y1 and Y2 are independently selected from hydrogen or alkyl; Z is =O or =S; R5, R6, R7 and R8 each independently represents hydrogen, -CF3, -COR10, alkyl or aryl, and further wherein R5 may be combined with R6 to represent =O or =S and/or R7 may be combined with R8 to represent =0 or =S; R10, R19 and R20 independently represent hydrogen, alkyl, alkoxy, aryl, aralkyl, heteroaryl, heteroarylalkyl, cycloalkyl, cycloalkylalkyl, heterocycloalkyl and heterocycloalkylalkyl, with the proviso that R19 and R20 are not both hydrogen and with the further proviso that when one of R19 or R20 is H, the other is not an unsubstituted straight or branched carbon chain;  v is zero, 1, 2 or 3; and w is zero or 1. The compounds are useful in treating abnormal growth of cells.
Patent NZ-501757-A (NZ)
Title: Dental floss formed from wound filaments, with ingestible binder, and flavouring or chemotherapeutic material
Inventor: MITHA AMIN
IPC: A61C15/00
Filed: 1998-05-28
Abstract: A dental floss is provided comprising a plurality of filaments of a substrate material formed into thread, an ingestible binder on the filaments which are bound to particles of encapsulated agents. The encapsulated agents are flavorants, sweeteners and chemotherapeutic agents. The encapsulation of the agents provides a uniform taste and distribution of chemotherapeutic agent on the floss.
Patent NZ-503340-A (NZ)
Title: Treatment for hairy hoof warts (papiliomatous digital dermatitis, or PDD)
Inventor: MEISTERS GEORGE J
IPC: A61P31/04
Filed: 1998-09-09
Abstract: An aqueous germicidal composition for the treatment or prevention of infectious diseases of the hoof in animals, comprising a copper salt, a quaternary ammonium compound, and a peroxide is described.  A method for treating or preventing infectious diseases of the hoof in animals, comprising topically administering the aforementioned aqueous germicidal composition is also described.